Conference Coverage
Conference Coverage
Challenges persist in adolescents with rheumatic disease transitioning to adult care
A successful transition from pediatric to adult rheumatology is crucial to maintain continuity of care for patients with rheumatic disease, but...
Conference Coverage
Modest clinical gain for AF screening of asymptomatic elderly: STROKESTOP
Literally all known 75- and 76-year-olds in two Swedish regions were included, whether or not they were screened by mobile ECG recorder. But does...
Conference Coverage
TNF inhibitors linked to threefold increased risk of psoriasis in JIA patients
Although this study confirms earlier research finding an increased risk of psoriasis after TNF inhibitor exposure, it does not necessarily change...
Conference Coverage
Psoriasis associated with an increased risk of COVID-19 in real-world study
Those treated with TNF-alpha inhibitors, methotrexate, and apremilast had statistically lower risks of COVID-19 vs. those on topical therapy.
Conference Coverage
Line of therapy matters for assessing biologic’s serious infection risk in RA
The risk for serious infection seen with tocilizumab is confounded by whether the drug is given as first-line or as subsequent treatment in the...
Conference Coverage
Half of patients in hospital for COVID-19 get acute kidney injury
It’s bad news when hospitalized COVID-19 patients develop acute kidney injury, which can prove fatal or can lead to the development or worsening...
Conference Coverage
COVID-19 linked to novel epileptic seizures
Among patients with new-onset seizures, hospital stays were about 15 days longer – and mortality rates were significantly higher.
Conference Coverage
Debate: Should biologics be used for milder cases of psoriasis?
The decision to use a biologic should hinge on how badly patients and their quality of life are affected, Dr. Langley said.
Conference Coverage
Tofacitinib: Small study shows big cutaneous sarcoidosis response
“Not only did patients get better, but they were in many cases able to come off their baseline immunosuppressive regimen."
Conference Coverage
Topical anticholinergic for axillary hyperhidrosis shows fewer side effects
The agent, which shows strong activity at the application site but reduced systemic activity, is moving through the U.S. regulatory process.
Conference Coverage
Hispanic diabetes patients receive less guideline-based care
A new study highlights disparities in health care.